- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 748
Sherlock catches $31m with Baidu’s help
Baidu Ventures has helped close a $31m series A round for Harvard-founded Sherlock Biosciences just over a month after the spinout launched with an initial $17.5m tranche.
Apr 25, 2019Corporates enter Cultivian Sandbox for $135m fund
Corteva Agriscience, ADM, Elanco, Ecolab, Griffith Foods, RD Offutt, Growmark, Koch Ag & Energy, Smithfield Foods and Sumitomo Chemical America all backed the VC firm's latest fund.
Apr 25, 2019Nocion plays nice to raise $27m
Nocion Therapeutics has raised $27m in a Partners Innovation Fund-backed series A round to develop drugs for pain and inflammation.
Apr 25, 2019Satsuma snatches $62m in series B round
Shin Nippon Biomedical Laboratories was among the investors in its spinoff, which is working on treatments for acute migraine.
Apr 25, 2019Harness picks up $60m
GV, ServiceNow Ventures and IVP co-led the series B round, which valued the AI-based software testing and deployment platform at $500m.
Apr 25, 2019EARDG Photonics looks into funding
UAVC has put capital into newly launched UA spinout EARDG Photonics, which integrates technology licensed from another spinout, TIPD, by the same co-founders.
Apr 25, 2019Slack returns to Astound in series B round
Slack Fund has taken part in a $15.5m series B round that increased the AI-based enterprise software developer's total funding to $27m.
Apr 25, 2019Nocion finds series A relief
Based on Harvard and Boston Children’s Hospital research, Nocion Therapeutics has raised $27m to develop drugs for pain and inflammation.
Apr 25, 2019Satsuma squeezes $62m out of series B
Osage University Partners has participated in a $62m series B round for Satsuma Pharmaceuticals, which also featured Shin Nippon Biomedical Laboratories.
Apr 25, 2019Norman nods to Bayer offer
Derek Norman has left Syngenta Ventures and joined Bayer Growth Ventures as vice-president, while Colin Steen has replaced him as head of the unit.
Apr 25, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


